Literature DB >> 23440486

No surgery for full-thickness rectal prolapse: what happens with continence?

Diane Cunin1, Laurent Siproudhis, Véronique Desfourneaux, Isabelle Berkelmans, Bernard Meunier, Jean-François Bretagne, Guillaume Bouguen.   

Abstract

BACKGROUND: Surgery is the only validated means of treating overt rectal prolapses, but both patients and physicians may decline or postpone the surgical approach. However, little is known on the functional outcome of nonoperated rectal prolapse. The aim of the present study was to highlight the natural history of overt rectal prolapse in patients for whom surgery was avoided or delayed. PATIENTS AND METHODS: A total of 206 patients complaining of full-thickness rectal prolapse were referred to a single institution that provided anorectal physiology for functional anorectal disorders. Standardized questionnaires, anorectal manometry, endosonography, and evacuation proctography constituted a prospective database. Fecal incontinence was evaluated with the Cleveland Clinic score (CCIS), and constipation was evaluated with the Knowles Eccersley Scott Symptom score (KESS).
RESULTS: Forty-two nonoperated patients (mean age: 61 ± 16 years) were compared to those of operated patients paired according to age and gender: the mean follow-up was 44 ± 26 months. The two groups had a similar past-history, follow-up, stool frequency, and main complaints, but lower quantified symptomatic scores and a better quality of life were reported in the nonsurgical group. At the end of follow-up, the nonsurgical group did not show any variation in CCI and KESS scores. By contrast, these two scores significantly improved in the rectopexy group. Sixteen nonoperated patients experienced a degradation of their continence status with an average increase of 5 ± 4.3 points of the CCIS. The patients with a CCIS <7 at referral were likely to deteriorate as compared to those having a higher score. Patients with a symptom history longer than 4 years never improved and in two-thirds continence deteriorated throughout the follow-up.
CONCLUSION: In the absence of the surgical option, patients with a 4-year duration of rectal prolapse and those with mild incontinence had no chance of improvement. These findings may be taken into account when surgery of rectal prolapse is not chosen.

Entities:  

Mesh:

Year:  2013        PMID: 23440486     DOI: 10.1007/s00268-013-1967-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  Laparoscopic ventral recto(colpo)pexy for rectal prolapse: surgical technique and outcome for 109 patients.

Authors:  A D'Hoore; F Penninckx
Journal:  Surg Endosc       Date:  2006-12       Impact factor: 4.584

2.  Defecography in normal volunteers: results and implications.

Authors:  P J Shorvon; S McHugh; N E Diamant; S Somers; G W Stevenson
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

Review 3.  Etiology and management of fecal incontinence.

Authors:  J M Jorge; S D Wexner
Journal:  Dis Colon Rectum       Date:  1993-01       Impact factor: 4.585

4.  Rectopexy to the promontory for the treatment of rectal prolapse. Report of 257 cases.

Authors:  J Loygue; B Nordlinger; O Cunci; M Malafosse; C Huguet; R Parc
Journal:  Dis Colon Rectum       Date:  1984-06       Impact factor: 4.585

5.  Linear discriminant analysis of symptoms in patients with chronic constipation: validation of a new scoring system (KESS).

Authors:  C H Knowles; A J Eccersley; S M Scott; S M Walker; B Reeves; P J Lunniss
Journal:  Dis Colon Rectum       Date:  2000-10       Impact factor: 4.585

Review 6.  Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults.

Authors:  C Norton; J D Cody; G Hosker
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

7.  Rectal adaptation to distension in patients with overt rectal prolapse.

Authors:  L Siproudhis; E Bellissant; F Juguet; M H Mendler; H Allain; J F Bretagne; M Gosselin
Journal:  Br J Surg       Date:  1998-11       Impact factor: 6.939

8.  Improvement in irritable bowel syndrome following ano-rectal surgery.

Authors:  Bernard V Palmer; W John Lockley; Robert B Palmer; Elena Kulinskaya
Journal:  Int J Colorectal Dis       Date:  2002-03-07       Impact factor: 2.571

9.  Clinical characteristics and quality of life in a cohort of 621 patients with faecal incontinence.

Authors:  Henri Damon; Anne Marie Schott; Xavier Barth; Jean Luc Faucheron; Laurent Abramowitz; Laurent Siproudhis; Marie-Odile Fayard; Cyrille Colin; Guy Valancogne; Véronique Bonniaud; François Mion
Journal:  Int J Colorectal Dis       Date:  2008-05-28       Impact factor: 2.571

10.  Anal sphincter morphology in patients with full-thickness rectal prolapse.

Authors:  Lee S Dvorkin; Christopher L H Chan; Charles H Knowles; Norman S Williams; Peter J Lunniss; S Mark Scott
Journal:  Dis Colon Rectum       Date:  2004-02       Impact factor: 4.585

View more
  5 in total

Review 1.  Abdominal Approaches to Rectal Prolapse.

Authors:  Kyla Joubert; Jonathan A Laryea
Journal:  Clin Colon Rectal Surg       Date:  2017-02

Review 2.  Consensus Statement of the Italian Society of Colorectal Surgery (SICCR): management and treatment of complete rectal prolapse.

Authors:  G Gallo; J Martellucci; G Pellino; R Ghiselli; A Infantino; F Pucciani; M Trompetto
Journal:  Tech Coloproctol       Date:  2018-12-15       Impact factor: 3.781

Review 3.  Evaluation, Diagnosis, and Medical Management of Rectal Prolapse.

Authors:  Jamie A Cannon
Journal:  Clin Colon Rectal Surg       Date:  2017-02

4.  Management of patients with rectal prolapse: the 2017 Dutch guidelines.

Authors:  E M van der Schans; T J C Paulides; N A Wijffels; E C J Consten
Journal:  Tech Coloproctol       Date:  2018-08-11       Impact factor: 3.781

5.  Evaluation of Pain and Distress and Therapeutic Interventions for Rectal Prolapse in Mice to Reduce Early Study Removal.

Authors:  Cara M Mitchell; Gregory W Salyards; Betty R Theriault; George P Langan; Kerith R Luchins
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-11-08       Impact factor: 1.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.